Take advantage of this opportunity to quickly gain a view of the current status of an individual class of drugs by purchasing this portion of HRA's industry leading formulary data set.
Updated annually, the "Snapshot" is ideally suited for brand managers,
market research executives, product managers, business development
and sales executives looking to answer healthcare business questions
related to brand planning, business development opportunities, in-licensing
deals and competitive and/or market share issues.
| Class "Snapshot"
Update Schedule |
|
 |
|
| |
|
|
|
| January |
Antipruritics
Hypoglycemics
Hypolipidemics
Anesthetic Agents |
| February |
Antifungal
Antitrichomonal Agents
Antivirals |
| March |
Hormones
Hormone Regulators
Muscle Relaxants
Central Nervous System |
| April |
Antisecretory
Antiulcer
Antispasmodics |
| May |
Anti-infectives |
| June |
AIDS Therapy |
| July |
Controlled Analgesics
Non-Narcotic Analgesics
Anti-arthritics
Anti-migraines |
| August |
Blood Modifiers |
| September |
Antineoplastics
Anti-infectives |
| October |
Anti-nauseants
Antiemetics
Pro-motility Agents |
| November |
Anti-infectives
Anti-fungals |
| December |
Anti-anxiety Agents
Anti-depressants
Anti-asthmatic agents
Bronchodialators
Sedatives |
|
|
- Current Formulary Status of all Products
- Current Restricted & Non-Restricted Status
|
To learn more about the HRA's Hospital Formulary Snapshot
or any of the proprietary research products within HRA Research's
Syndicated service line, please call (973) 240-1200.
>> Syndicated Research
| 
